Thursday's session: top gainers and losers

SPERO THERAPEUTICS INC (SPRO)       1.89   -0.05 (-2.58%)


News Image
Thursday's session: top gainers and losers2 months ago - Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session.

Top gainers

TickerChangeComment
SPRO205.0%SPERO THERAPEUTICS INC's (NASDAQ:SPRO) stock price is advancing with 205.0% to a price of $2.5. In the last 6 months the stock lost 89.92%.
BOA.W100.0%BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price is advancing with 100.0% to a price of $0.14. The stock is trading 65.5% lower than 3 months ago.
AVCTW39.86%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares rose 39.86% to $0.06. Shareholders saw the stock price going 30.59% higher in the past 3 months.
AVCT39.03%AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price increased by 39.03% to $0.3. Shareholders saw the stock price going 53.27% higher in the past month.
BEAT31.73%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 31.73% to $2.08. In the last month the share price increased with 20.61%.
SONN22.73%SONNET BIOTHERAPEUTICS HOLDI's (NASDAQ:SONN) stock price is advancing with 22.73% to a price of $1.62. In the last month the stock lost 60.53%.
TALK19.99%TALKSPACE INC (NASDAQ:TALK) rose 19.99% to $1.0 during Thursday's after hours session. In the last month the share price dropped with 46.92%.
SAVA19.85%CASSAVA SCIENCES INC's (NASDAQ:SAVA) shares rose 19.85% to $45.11 during Thursday's session. In the last month the share price increased with 48.72%.
USEA19.74%UNITED MARITIME CORP's (NASDAQ:USEA) stock price increased by 19.74% to $1.82.
PIXY18.65%SHIFTPIXY INC's (NASDAQ:PIXY) stock price increased by 18.65% to $16.21. In the last month the share price dropped with 41.32%.

For the full top gainers list go to our top gainers screener.

Today's top losers

TickerChangeComment
OPP--38.46%River North Dble Line Strtgc Opp Fd [Opp/I/R]'s (NYSE:OPP-) stock price is declining with 38.46% to a price of $0.0. In the last month the stock lost 97.61%.
BCAN-26.3%BYND CANNASOFT ENTERPRISES's (NASDAQ:BCAN) shares fell 26.3% to $3.25.
MOHO-25.88%ECMOHO LTD's (NASDAQ:MOHO) shares fell 25.88% to $0.13 during Thursday's session. The stock is trading 31.61% lower than 6 months ago.
TOPS-25.19%TOP SHIPS INC's (NASDAQ:TOPS) shares fell 25.19% to $0.16 during Thursday's session. In the last month the stock lost 29.7%.
CPTN-22.92%CEPTON INC's (NASDAQ:CPTN) shares fell 22.92% to $1.61 during Thursday's session. Yesterday the company had a press release: Cepton Adds Lidar Digital Twin to NVIDIA DRIVE Sim, Advancing the Development of Safe Autonomous Driving Technology.
SOBR-20.92%SOBR SAFE INC's (NASDAQ:SOBR) shares fell 20.92% to $1.89. In the last month the stock gained 115.0%.
LAZR-20.4%LUMINAR TECHNOLOGIES INC's (NASDAQ:LAZR) shares fell 20.4% to $7.46. The stock is trading 25.1% higher than 3 months ago.
AGRI-19.74%AGRIFORCE GROWING SYSTEMS LT's (NASDAQ:AGRI) stock price is declining with 19.74% to a price of $1.42. Shareholders saw the stock price going 29.2% lower in the past 3 months.
SLNG-16.07%STABILIS SOLUTIONS INC's (NASDAQ:SLNG) stock price decreased by 16.07% to $7.42. In the last month the share price increased with 89.7%.
IMTE-16.03%INTEGRATED MEDIA TECHNOLOGY's (NASDAQ:IMTE) shares fell 16.03% to $0.61 during Thursday's session. The stock is trading 47.03% lower than a month ago.

To see the full list of top losers you can use our top losers screener.

Back

SPRO Links

SPRO News

News Image9 days ago - Spero Therapeutics, Inc.Spero Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...

News Image17 days ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Third Quarter 2022 Operating Results and Provides Business Update

Entered into and closed exclusive license agreement with GSK for tebipenem HBr, pursuant to which Spero receives $66 million upfront, and a $9 million...

News Image23 days ago - Spero Therapeutics, Inc.Spero Therapeutics Announces Closing of Exclusive License Agreement with GSK for Tebipenem HBr

Pursuant to the agreement, Spero will be receiving a $66 million upfront payment, received a $9 million direct equity investment in shares of Spero common...

News Image24 days ago - Spero Therapeutics, Inc.Spero Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on Monday, November 14, 2022

CAMBRIDGE, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Imagea month ago - Spero Therapeutics, Inc.Spero Therapeutics to Present Data at IDWeek 2022

CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...

News Image2 months ago - Spero Therapeutics, Inc.Spero Therapeutics to Host Virtual R&D Event on Non-Tuberculous Mycobacterial Pulmonary Disease and the SPR720 Program

Event is taking place on Thursday, October 6th at 11:30 a.m. ET Event will feature a presentation by key opinion leader, Kevin L. Winthrop, MD, MPH...

Follow us for more